Overview (18 Sep 2020)
SUVEN LIFE SCIENCES LTD.
SUVEN
INE495B01038

Pharmaceuticals
Result was last declared on 11 Aug 2020
4.9

Prev. Close
Previous Close
51.55
Current Close
56.45
Current High
56.7
Current Low
51.55
52 Week High
334.7
52 Week Low
15.2
Resistance 1
58.25
Resistance 2
60.05
Support 1
53.10
Support 2
47.95
Std Deviation
8.89%
DMA 200
81.46
DMA 50
46.04
DMA 20
50.61
Fundamentals and Ratios
Standalone
Trailing EPS
-1.08
Forwad EPS
-1.16
Trailing P/E
NA
Forward P/E
NA
PEG Ratio
NA
Mkt. Cap (Cr)
Market Cap (Cr)
718.51
Total Debt(Cr)
Tot. Debt(Cr)
19.39
Reserve (Cr)
130.62
Book Value
11.24
P/BV Ratio
5.02
ROCE(%)
61.00
ROE
43.00
Consolidated
Trailing EPS
-7.4
Forwad EPS
-6.16
Trailing P/E
-7.63
Forward P/E
-9.16
PEG Ratio
0
Mkt. Cap (Cr)
Market Cap (Cr)
718.51
Total Debt(Cr)
Tot. Debt(Cr)
19.39
Reserve (Cr)
130.62
Book Value
11.21
P/BV Ratio
5.04
ROCE(%)
27.00
ROE
3.00

 

Financial Result
Standalone
TypeJun-20Mar-20Dec-19Sep-19Jun-19FY19-20
Revenue1.438.662.77274.32198.9914.42
Other Income2.533.005.865.593.0114.04
Total Income3.9611.668.63279.90201.9928.45
Interest0.220.230.101.851.310.54
Expenditure-10.50-12.02-13.09-171.23-115.81-54.39
PBDT0.000.000.000.000.000.00
Depreciation-1.07-1.05-0.86-5.59-5.55-4.17
PBT-6.55-0.37-4.46108.6886.18-25.94
Tax2.47-2.20-0.04-36.36-29.0012.18
Equity0.000.000.000.000.000.00
OPM-458.01-4.21-160.8039.6242.67-91.00
Net Profit-4.08-2.56-4.572.3257.18-13.75
NPM-285.3-29.61-162.3526.3628.31-48
EPS-0.32-0.2-0.355.684.49-1.08
Consolidated
TypeJun-20Mar-20Dec-19Sep-19Jun-19FY19-20
Revenue1.438.662.77274.32198.9914.42
Other Income2.533.005.865.593.0114.04
Total Income3.9611.668.63279.90201.9928.45
Interest0.220.230.102.291.690.55
Expenditure-16.91-35.02-31.40-180.24-146.78-134.85
PBDT0.000.000.000.000.000.00
Depreciation-1.07-1.05-0.86-5.59-5.55-4.17
PBT-12.96-23.36-22.7799.6655.21-106.40
Tax2.47-2.20-0.04-36.35-29.0012.18
Equity0.000.000.000.000.000.00
OPM-327.36-200.39-263.9235.6027.33-373.98
Net Profit-10.49-25.56-22.8163.3126.21-94.22
NPM-265.01-219.25-264.4222.6212.98-331.16
EPS-0.82-2.01-1.794.972.06-7.4
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2019Interim Divvidend1.50Interim Dividend - Rs. - 1.500014 Feb 2019
2018Interim Divvidend1.50Interim Dividend - Rs. - 1.500006 Feb 2018
2017Interim Divvidend1.00Interim Dividend - Rs. - 1.000008 Feb 2017
2016Interim Divvidend1.00Interim Dividend - Rs. - 1.000014 Mar 2016
2016Special Dividend1.00Special Dividend - Rs. - 1.000014 Mar 2016
2015Final Dividend0.60Dividend - Rs. - 0.600023 Jul 2015
2014Final Dividend0.50Dividend - Rs. - 0.500024 Jul 2014
2014Final Dividend0.50Dividend - Rs. - 0.500024 Jul 2014
2014Special Dividend2.00Special Dividend - Rs. - 2.000024 Jul 2014
2014Special Dividend2.00Special Dividend - Rs. - 2.000024 Jul 2014
2013Final Dividend0.30Dividend - Rs. - 0.300001 Aug 2013
2012Final Dividend0.30Dividend - Rs. - 0.300017 Sep 2012
2011Final Dividend0.25Dividend - Rs. - 0.250001 Aug 2011
2010Final Dividend0.25Dividend - Rs. - 0.250019 Jul 2010
2009Final Dividend0.25Dividend - Rs. - 0.250014 Sep 2009
2008Final Dividend0.25Dividend - Rs. - 0.250011 Sep 2008
Bonus
Split

Mutual Fund Holddings
Sector: Pharmaceuticals
CompanyCurrent CloseP/E Ratio
8KMILES
38.95
24.34
AARTIDRUGS
2967.35
51.06
ABBOTINDIA
16506.15
59.15
AJANTPHARM
1613.1
31.91
ALBERTDAVD
449.25
13.37
ALEMBICLTD
118.1
32.45
ALKEM
2874.85
27.19
AMBALALSA
19.75
9.73
ANUHPHR
206.3
72.26
APLLTD
963.55
18.74
ARCHITORG
12.57
-23.72
AREYDRG
30.1
12.14
ARMOURPO
57.8
13.05
ASTRAZEN
4296.8
148.78
AUROLAB
57.25
8.79
123456789
Connect @
Important Links
BSE
NSE
Copyright: IndiaOne Media 2020